Clinical trial

Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use

NCT02794480

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention ELLIPTA DPI Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention GSK MDI Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention AZ MDI Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-08-22

PhasePHASE4

Conditions

Asthmaverified · MONDO: asthma

Interventions

ELLIPTA DPIDEVICE

GSK MDIDEVICE

AZ MDIDEVICE

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

BaltimoreMaryland, United States1 MiamiFlorida, United States1 San AntonioTexas, United States1 CincinnatiOhio, United States1 Oklahoma CityOklahoma, United States1 CharlotteNorth Carolina, United States1 RaleighNorth Carolina, United States1 SpartanburgSouth Carolina, United States1 CantonOhio, United States1 ClearwaterFlorida, United States1 ColumbiaMissouri, United States1 MedfordOregon, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02794480 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.